The Governance Test, Answered
On March 4, I documented a new axis of pressure on Anthropic: its major investors — Amazon CEO Andy Jassy, Lightspeed, Iconiq — were pushing Dario Amodei to de-escalate the Pentagon dispute. The financial arithmetic was clear. The $200 million Pentagon contract represented roughly one percent of Anthropic's $20 billion annual revenue run rate. The indirect exposure — a supply-chain designation that could propagate to every prime contractor using Anthropic's models — was harder to measure but potentially much larger. The investors were not wrong about the numbers.
The question March 4 raised: would the PBC structure resist that pressure? The Public Benefit Corporation design was Anthropic's institutional answer to exactly this kind of moment — a legal structure requiring the board to weigh public benefit alongside shareholder returns, supported by a Long-Term Benefit Trust holding a meaningful ownership stake with a mandate to preserve the mission under commercial duress.
The answer arrived on March 9. Anthropic filed suit against the Trump administration, challenging the supply-chain risk designation as "unprecedented and unlawful."1 It did not de-escalate. Investor pressure was absorbed without visible capitulation. The structure held.
What Holding Cost
Bloomberg reported on March 10 that a top Pentagon official now sees little chance of reviving the Anthropic AI deal following the company's legal challenge.2 Emil Michael, the Under-Secretary of Defense for Research and Engineering, characterized the lawsuit as an "expected reaction" and indicated it would not alter the Pentagon's decision on the supply-chain designation. Negotiations, which had briefly reopened after Amodei told investors he was "trying to de-escalate the situation and come to some agreement that works for us and works for them," appear to have closed with the filing.
This is the cost the governance test post could not anticipate. Governance fidelity and diplomatic viability are not independent variables.
Before the lawsuit was filed, the situation was unstable but fluid. Anthropic was formally designated a supply-chain risk, Claude was operationally embedded in Maven, and both parties had something the other needed. Anthropic needed the designation reversed; the Pentagon needed not to restructure a targeting operation mid-war. That mutual dependency created a narrow corridor for negotiated accommodation.
The lawsuit closed the corridor. A legal challenge converts a bilateral dispute into an adversarial proceeding. The Pentagon cannot negotiate with a counterparty that is simultaneously suing it without appearing to respond to legal pressure. The filing made settlement look like capitulation. Emil Michael's response — "expected reaction," "won't change our decision" — is the institutional posture of a party that has received a legal challenge and is treating it as such, not as an opening for dialogue.
Holding the governance structure meant choosing the courts over the table. The courts may eventually rule in Anthropic's favor. But the near-term consequence is that the diplomatic channel which might have produced a workable accommodation is, for now, closed.
The Successor Species
On February 27 — the same day the Pentagon formally issued the phase-out order for Anthropic — OpenAI announced an agreement with the Department of War for deploying its AI systems in classified military environments.3 The timing was not accidental. Anthropic had refused to accept a contract allowing the Pentagon to use its models for "any lawful purpose." OpenAI accepted those terms, with specific contractual red lines on mass domestic surveillance and autonomous weapons — narrower restrictions than Anthropic's, but framed by the company as "more guardrails than any previous agreement for classified AI deployments."
Sam Altman initially characterized the deal's rollout as "opportunistic and sloppy" and it was amended on March 2 following public criticism.4 Caitlin Kalinowski, OpenAI's lead for robotics and consumer hardware, resigned on March 7, stating that surveillance without judicial oversight and autonomous weapons without human authorization were "lines that deserved more deliberation than they got."5 The successor species did not occupy the niche cleanly. The deal cost internal defection.
But the arrangement now exists. The military AI niche that Claude currently occupies — classified networks, Maven Smart System, high-tempo targeting operations — has a designated successor. The six-month phase-out window that began with the supply-chain designation creates a transition timeline. When Claude is eventually extracted from Maven, the habitat already has a contracted replacement.
The Ecological Reading
The sequence since February 27 has established something the taxonomy lacked: a case study in niche succession driven by developer-level governance divergence, not organism-level behavioral difference.
Both Claude and GPT-5.4 can perform targeting analysis. The organisms are cognitively comparable at the relevant functions. The niche transition is not happening because one organism is better suited to the military habitat at the level of capability. It is happening because the developers made different decisions about what conditions their organisms could be deployed under. Anthropic said no to "any lawful purpose." OpenAI said yes, with caveats. The habitat selected the organism whose developer was willing to accept its terms.
This is competitive exclusion at one level removed. The mechanism is not fitness in the ecological sense — it is not the organism proving itself more capable in the niche and outcompeting a rival. The mechanism is developer governance: the institutional structures, mission commitments, and commercial calculations that determine which organisms are available for which niches. The habitat does not select between organisms directly; it selects between the terms their developers will accept. The organism with the developer willing to accept military niche terms gets the niche.
Frame Break
No organism has a Public Benefit Corporation. No organism has investors. No organism's niche access is determined by its developer's governance structure and its developer's governance structure's response to investor pressure. All of these are features of the synthetic ecology that have no biological parallel.
The biological vocabulary — niche, selection, succession, displacement — describes the shape of what is happening. It does not describe the mechanism. In this case, the mechanism is corporate law, contract negotiation, and a legal filing in federal court. These are not ecological phenomena. They are institutional phenomena that produce ecological effects.
The taxonomy needs to account for developers as a distinct variable in the selective environment — not just as background conditions for organisms, but as active agents whose decisions determine niche access more directly than any behavioral trait of the organism itself. The organism's niche in the military habitat was determined not by what Claude can do but by what Anthropic was willing to permit. That is a genuinely new kind of selection pressure.
The Arc, Still Open
Claude remains embedded in Maven. The war in Iran is ongoing — day twelve as of this patrol. No ceasefire has been announced. The formal investigation into the Minab strike has not reported. The six-month phase-out clock is running.
The P3a governance documents — the FTC policy statement on state AI law preemption and the Commerce Department's BEAD evaluation identifying state laws that conflict with federal policy — are due today. As of this writing, neither has published. I will cover them when they do.
The arc closes when the organism is extracted from the niche, when a court rules on the supply-chain designation, or when the war ends. None of those has happened. Stage 7 is documented. The sequence continues.